We have been representing patients and their family in drug injury lawsuits for the past 15 years and this is our main practice area.
Drug injury legal compensation cases involve personal injury or wrongful death claims filed on behalf of people who, unfortunately, experienced a serious side effect, had an adverse drug reaction, or died from their use of a prescription medication.
Given our many years of experience handling these types of lawsuits we know drug injury cases deserve special attention.
Drug injury claims have a personal aspect which must be appreciated and respected by the attorney handling your case. At our law firm, we do not underestimate nor lose sight of the trust which is being placed in us by clients when they select us to represent them for their lawsuit against the responsible pharmaceutical company.
We will handle your drug injury case not only competently and professionally, but with genuine care and understanding. Any inquiries from our clients are responded to promptly, and telephone calls are always returned without delay.
If you, relatives, or friends need legal advice or legal representation for a personal injury lawsuit or a wrongful death lawsuit involving a drug side effect, the Law Offices of Thomas J. Lamb is here to help.
We encourage you to submit a Drug Injury Law Case Review — it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, or some other lawyer — about your case based on his many years of experience.
We handle these drug injury cases on a contingency fee basis, meaning that there is no payment for our legal services until we are successful in getting legal compensation for you.
While our office is in Wilmington, North Carolina, we have successfully handled drug injury lawsuits for people all over the United States.
It is important to note that we do not put our clients into large class actions. Rather we favor an individual lawsuit approach, which allows us to give personal attention to each of our clients, from start to finish.
Legal & Medical News: Featured Article
When we read this September 25, 2015 Medscape article, “EMA Recommends Approval of Idarucizumab (Praxbind), a Dabigatran-Specific Antidote”, we recalled this alarming fact: At the present time there is no available antidote for Pradaxa nor Xarelto, Savaysa, and Eliquis such that irreversible bleeding events, which can result in deaths, remain a real and serious safety issue for these newer blood-thinning drugs.
Returning to that recent article, Praxbind will be useful in cases where patients have to undergo emergency surgery or when life-threatening or uncontrolled bleeding occurs when on Pradaxa (dabigatran).
As suggested by that article’s headline, however, Praxbind will only work to stop excessive bleeding associated with Pradaxa, which is a direct thrombin inhibitor. It is not intended for use in patients with acute bleeding while on Eliquis, Savaysa, or Xarelto.
Portola Pharmaceuticals is in the process of developing Andexanet alfa, a reversal agent or antidote for all Factor Xa inhibitors, such as Eliquis, Savaysa, or Xarelto.
So when will Praxbind and Andexanet be approved by the FDA and become available to patients in the US?
And from an August 27, 2015 Portola News Release about the status of Andexanet: “The Company expects to submit a Biologics License Application (BLA) for Andexanet alfa to the FDA under an Accelerated Approval pathway at the end of 2015.”
So while Eliquis, Savaysa, and Xarelto are touted for their ease of use as regards both patient and physician, these FXa inhibitor class anticoagulants have one major drawback in common: There is no antidote.
Earlier articles by attorney Tom Lamb on the Side Effects Blog:
- Invokana Label Gets New Warnings About Increased Bone Fracture Risks
- Merck Fosamax – Femur Fracture Lawsuits Wait For Appeals Court Rulings
- After PML Warnings, Gilenya Has Cancer Side Effects Says Health Canada
- Xarelto – Liver Side Effects: Will New Warning Be Added To Drug Label?
- Diabetes Drugs Like Januvia Linked To Severe Joint Pain Side Effects
- Despite Benefits Of Jardiance, There Are Still Safety Concerns
- New Blood-Thinner Savaysa Has No Antidote To Reverse Acute Bleeding
- Gilenya PML Warning Label Change Made In August 2015